Results for "Cell and Gene Therapy"

The FDA's Hidden Bet: Why Manufacturing Flexibility in Cell Therapy Is Actually a Trojan Horse for Consolidation

The FDA is granting manufacturing flexibility for cell and gene therapies. But the real story isn't access; it’s who benefits from this regulatory shift in biopharma.